Skip to content

Author

Sheng-Xiang Ren

We have 2 of 47 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Open access Oct 2026

Camrelizumab plus chemotherapy as induction therapy followed by concurrent chemoradiotherapy and camrelizumab consolidation in limited-stage small cell lung cancer: a randomized phase II trial

Definitive chemoradiotherapy followed by immunotherapy consolidation is the current standard of care for limited-stage small cell lung cancer (LS-SCLC). We conducted a randomized phase II trial (ChiCTR2000032275) to evaluate a camrelizumab-based induction–consolidation strategy in previously untreated patients with LS-...

Di Liu, Le-Tong Yang, Min-Ren Hu et al. · 0 citations
Sep 2026

UniCure: A multi-modal model for predicting personalized cancer therapy response.

UniCure is presented, a multi-modal model that combines biological and chemical foundation models to predict drug-induced transcriptomic responses across diverse cell and tissue contexts, enabling individualized drug ranking.

Ze-Xi Chen, Saisai Tian, Jia-Zheng Pei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.